Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Candida albicans cells with increased cell wall chitin have reduced echinocandin susceptibility in vitro . The aim of this study was to investigate whether C. albicans cells with elevated chitin levels have reduced echinocandin susceptibility in vivo . BALB/c mice were infected with C. albicans cells with normal chitin levels and compared to mice infected with high-chitin cells. Caspofungin therapy was initiated at 24 h postinfection. Mice infected with chitin-normal cells were successfully treated with caspofungin, as indicated by reduced kidney fungal burdens, reduced weight loss, and decreased C. albicans density in kidney lesions. In contrast, mice infected with high-chitin C. albicans cells were less susceptible to caspofungin, as they had higher kidney fungal burdens and greater weight loss during early infection. Cells recovered from mouse kidneys at 24 h postinfection with high-chitin cells had 1.6-fold higher chitin levels than cells from mice infected with chitin-normal cells and maintained a significantly reduced susceptibility to caspofungin when tested in vitro . At 48 h postinfection, caspofungin treatment induced a further increase in chitin content of C. albicans cells harvested from kidneys compared to saline treatment. Some of the recovered clones had acquired, at a low frequency, a point mutation in FKS1 resulting in a S645Y amino acid substitution, a mutation known to confer echinocandin resistance. This occurred even in cells that had not been exposed to caspofungin. Our results suggest that the efficacy of caspofungin against C. albicans was reduced in vivo due to either elevation of chitin levels in the cell wall or acquisition of FKS1 point mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Based on previous research [66–68], to quantify the β-glucan and mannan content within the cell wall, the strains of WT, num11Δ/Δ, and num11Δ/NUM11N were cultivated overnight in 100 milliliters of fresh YPD liquid medium at 30°C and 200 rpm.”
From Mitochondrial anchor protein Num11 is key to pathogenicity of Candida albicans by affecting mitochondrial function and cell wall masking (2025) · cites this paper as [67]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Thus, mutations at these hot spots have been linked to a) impaired enzyme capacity, b) altered cell wall composition, i.e. reduced glucan and increased chit in content, c) increased cell wall thickness and d) impaired filamentation properties, which contribute to a lower growth rate in vitro and in vivo in drosophila and mouse models (31–33).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [33]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, mutations at these hot spots have been linked to a) impaired enzyme capacity, b) altered cell wall composition, i.e. reduced glucan and increased chit in content, c) increased cell wall thickness and d) impaired filamentation properties, which contribute to a lower growth rate in vitro and in vivo in drosophila and mouse models (31–33).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Echinocandin resistance in Candida has been linked to loss of fitness for homozygous Fks1p F641 and S645 mutants of C. albicans and Fks2p S663P mutants of C. glabrata (31–33).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For example, conditions that increase cell wall chitin promote cell survival in the presence of echinocandin76,77, whereas calcineurin inhibitors reduce echinocandin tolerance (measured using MIC assays analyzed after 72 h)68,78.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [77]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Hoffman, C. S., & Winston, F. (1987) · Gene · doi:10.1016/0378-1119(87)90131-4 · Cited by 2,479
Isogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,687
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131 · cited 1×
“and are effective against Candida isolates which are resistant to other antifungal drugs, such as azoles (16, 51, 54).”
BackgroundConserved Fungal LysM Effector Ecp6 Prevents Chitin-Triggered Immunity in Plants
de Jonge, R., Peter van Esse, H., Kombrink, A., Shinya, T., Desaki, Y., Bours, R., van der Krol, S., Shibuya, N., Joosten, M. H. A. J., & Thomma, B. P. H. J. (2010) · Science · doi:10.1126/science.1190859 · Cited by 777
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698
Resistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512 · cited 3×
“S645Y is a common mutation in Fks1 HS1 associated with decreased sensitivity to echinocandins (50, 51).”
BackgroundChitin synthesis and fungal pathogenesis
Lenardon, M. D., Munro, C. A., & Gow, N. A. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.002 · Cited by 502
Self-citationStimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins
Walker, L. A., Munro, C. A., de Bruijn, I., Lenardon, M. D., McKinnon, A., & Gow, N. A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000040 · Cited by 445 · cited 10×
“albicans strains with FKS1 hot-spot mutations have increased chitin content compared to wild-type strains (4, 70).”
BackgroundMethodResultSelf-citationPark, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434
Research works printed but not linked: 1
- 10.1128/mmbr.61.2.170-192.1997 · doi:10.1128/mmbr.61.2.170-192.1997 · Paper page
Cited by
Items 101–200 of 210
Epidemiology of Echinocandin Resistance in Candida
Grossman, N. T., Chiller, T. M., & Lockhart, S. R. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0209-7 · Cited by 28
Moráňová, Z., Virtudazo, E. V., Hricová, K., Ohkusu, M., Kawamoto, S., Husičková, V., & Raclavský, V. (2013) · Biomedical Papers · doi:10.5507/bp.2013.024 · Cited by 34
Caspofungin-induced β(1,3)-glucan exposure in Candida albicans is driven by increased chitin levels
Wagner, A. S., Lumsdaine, S. W., Mangrum, M. M., & Reynolds, T. B. (2023) · mBio · doi:10.1128/mbio.00074-23 · Cited by 26
Candida parapsilosis Sensu Stricto Antifungal Resistance Mechanisms and Associated Epidemiology
Franconi, I., Rizzato, C., Poma, N. V., Tavanti, A., & Lupetti, A. (2023) · Journal of Fungi · doi:10.3390/jof9080798 · Cited by 29
Rodrigues, J., Ramos, C. L., Frasés, S., Godinho, R. M. D. C., Fonseca, F. L., & Rodrigues, M. L. (2018) · The Cell Surface · doi:10.1016/j.tcsw.2018.05.002 · Cited by 30
“In the same pathogen, elevated cell wall chitin conferred echinocandin resistance in vivo (Lee et al., 2012).”
BackgroundCurrent and promising pharmacotherapeutic options for candidiasis
Scorzoni, L., Fuchs, B. B., Junqueira, J. C., & Mylonakis, E. E. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1873951 · Cited by 36
“infection can provide new perspectives to improve the drug efficacy [141].”
BackgroundSynthesis of novel proxyphylline derivatives with dual Anti-Candida albicans and anticancer activity
Borowiecki, P., Wińska, P., Bretner, M., Gizińska, M., Koronkiewicz, M., & Staniszewska, M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.077 · Cited by 28
Review on fungal enzyme inhibitors – potential drug targets to manage human fungal infections
Ramakrishnan, J., Rathore, S. S., & Raman, T. (2016) · RSC Advances · doi:10.1039/c6ra01577h · Cited by 28
Moretti, S., Bozza, S., D'Angelo, C., Casagrande, A., Della Fazia, M. A., Pitzurra, L., Romani, L., & Aversa, F. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05198-11 · Cited by 24
“Consistent with the observation that an intense cell wall remodeling has been observed after the exposure of fungal cells to CAS (21, 28), even under conditions of paradoxical fungal growth (6), one likely mechanism underlying the contribution of innate receptors to CAS activity is that different fungal PAMPs, in addi…”
BackgroundSignalling mechanisms involved in stress response to antifungal drugs
Víglaš, J., & Olejníková, P. (2020) · Research in Microbiology · doi:10.1016/j.resmic.2020.10.001 · Cited by 24
Tulbaghia violaceaHarv. plant extract affects cell wall synthesis inAspergillus flavus
Belewa, V., Baijnath, H., Frost, C. L., & Somai, B. M. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13405 · Cited by 22
“…have developed compensatory mechanisms for the loss of one component (such as b-glucans) by increasing the production of another (e.g. chitin) contributing to the development of resistance towards the antifungal agent (Walker et al. 2008; Fortwendel et al. 2009; Lee et al. 2012; Rogg et al. 2012).”
BackgroundDavari, A., Haghani, I., Hassanmoghadam, F., Nabili, M., Shokohi, T., Hedayati, M. T., Shabanzadeh, S., & Moazeni, M. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.06.025 · Cited by 25
Multilocus sequence typing of azole-resistant Candida auris strains, South Africa
Magobo, R. E., Mhlanga, M., Corcoran, C., & Govender, N. P. (2020) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v35i1.116 · Cited by 22
de Oliveira, W. F., Cabrera, M. P., Santos, N. R. M., Napoleão, T. H., Paiva, P. M. G., Neves, R. P., da Silva, M. V., Santos, B. S., Coelho, L. C. B. B., Filho, P. E. C., et al. (2019) · Microbiological Research · doi:10.1016/j.micres.2019.126330 · Cited by 25
Yeoh, S. F., Lee, T. J., Chew, K. L., Lin, S., Yeo, D., & Setia, S. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s165676 · Cited by 20
“47,48 Above all, echinocandin resistance is significant among LTRs with IAC (4.8%), especially in those under long exposure.”
InfluentialSurface, adhesiveness and virulence aspects of Candida haemulonii species complex
Ramos, L. S., Oliveira, S. S. C., Silva, L. N., Granato, M. Q., Gonçalves, D. D. S., Frasés, S., Seabra, S. H., Macêdo, A. J., Kneipp, L. F., Branquinha, M. H., et al. (2020) · Medical Mycology · doi:10.1093/mmy/myz139 · Cited by 20
The Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport
Zavřel, M., Esquivel, B. D., & White, T. C. (2017) · Springer eBooks · doi:10.1007/978-1-4939-0694-9_29 · Cited by 24
“albicans cells respond to echinocandin treatment with an increase in chitin levels, and strains with higher chitin content in cell wall (including those naturally occurring) are less echinocandin susceptible (Plaine et al. 2008; Lee et al. 2012).”
BackgroundPost-transcriptional control of fungal cell wall synthesis
Hall, R. A., & Wallace, E. W. J. (2022) · The Cell Surface · doi:10.1016/j.tcsw.2022.100074 · Cited by 24
Usher, J., Ribeiro, G. F., & Childers, D. S. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03724-22 · Cited by 17
“Modifications in mannosylated proteins or their abundance as well as to immunomodulatory carbohydrates, including b-1,3-glucan and chitin, can promote immune evasion, tolerance, or severe inflammation (52, 54).”
BackgroundPellón, A., Ramirez‐Garcia, A., Buldain, I., Antoran, A., Rementería, A., & Hernando, F. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174885 · Cited by 20
Perrine-Walker, F. M. (2022) · Brazilian Journal of Microbiology · doi:10.1007/s42770-022-00739-9 · Cited by 23
Hameed, S., Hans, S., Singh, S., Dhiman, R., Monasky, R. C., Pandey, R. P., Thangamani, S., & Fatima, Z. (2021) · Pathogens · doi:10.3390/pathogens10080942 · Cited by 20
Exploring the In Vitro Resistance of Candida parapsilosis to Echinocandins
Chassot, F., Venturini, T. P., Piasentin, F. B., Rossato, L. L., Fiorini, A., Svidzinski, T. I. E., & Alves, S. H. (2016) · Mycopathologia · doi:10.1007/s11046-016-0028-1 · Cited by 20
Neutralization of Pathogenic Fungi with Small‐Molecule Immunotherapeutics
Chirkin, E., Muthusamy, V., Mann, P. A., Roemer, T., Nantermet, P. G., & Spiegel, D. A. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707536 · Cited by 18
Tetraploidy accelerates adaptation under drug selection in a fungal pathogen
Avramovska, O., Smith, A. C., Rego, E., & Hickman, M. A. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.984377 · Cited by 18
“, 2021) and remodeling of the fungal cell wall through increased chitin synthesis (Lee et al., 2012; De Cesare et al., 2022) are mechanisms linked to echinocandin tolerance.”
BackgroundZEBRA cell‐penetrating peptide as an efficient delivery system in Candida albicans
Marchione, R., Daydé, D., Lenormand, J., & Cornet, M. (2014) · Biotechnology Journal · doi:10.1002/biot.201300505 · Cited by 19
Silver nanoparticles: an upcoming therapeutic agent for the resistant Candida infections
Perween, N., Khan, H. M., & Fatima, N. (2019) · Journal of Microbiology & Experimentation · doi:10.15406/jmen.2019.07.00240 · Cited by 18
Biomarkers of caspofungin resistance in Candida albicans isolates: A proteomic approach
Cesare, G. B. D., Hafez, A. I., Stead, D., Lloréns, C., & Munro, C. A. (2022) · Virulence · doi:10.1080/21505594.2022.2081291 · Cited by 19
“Car1 is a caspofungin-resistant strain recovered from the kidneys of mice treated with caspofungin, which were infected with the Ca1 strain [33].”
BackgroundSelf-citationMicrobiota and fungal-bacterial interactions in the cystic fibrosis lung
Santos-Fernandez, E., Martin–Souto, L., Antoran, A., Areitio, M., Aparicio-Fernandez, L., Bouchara, J., Schwarz, C., Rementería, A., Buldain, I., & Ramirez‐Garcia, A. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad029 · Cited by 17
Gabaldón, T. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00029-23 · Cited by 19
“…C. albicans , N. glabratus , and Candida krusei (6, 41), but other mechanisms have been discussed such as mutations altering the regulatory protein Rho1 (42), activation of the calcineurin-dependent stress pathway (42, 43), or mutations affecting the ergosterol desaturase encoded by ERG3 (44, 45).”
Identification of an indole–triazole–amino acid conjugate as a highly effective antifungal agent
Pawar, K., Yadav, A., Prasher, P., Mishra, S., Singh, B., Singh, P., & Komath, S. S. (2015) · MedChemComm · doi:10.1039/c5md00156k · Cited by 15
Multi trace element profiling in pathogenic and non-pathogenic fungi
Wehmeier, S., Morrison, E. L., Plato, A., Raab, A., Feldmann, J., Bedekovic, T., Wilson, D., & Brand, A. (2020) · Fungal Biology · doi:10.1016/j.funbio.2020.03.001 · Cited by 16
“…Zn and Mo. Lastly, we 101 quantified the effect on the trace element profile of treating C. albicans cells with Calcofluor White 102 and high extracellular Ca, a standard laboratory method for inducing cell wall stress in the study of 103 antifungal drugs (Lee et al., 2012; Walker et al., 2008).”
BackgroundLi, Q., Zhao, Y., & Xie, Y. (2021) · Foods · doi:10.3390/foods10122951 · Cited by 14
“, echinocandins [18] and nikkomycin [19]) against cell walls of A.”
BackgroundGoren, I., Godny, L., Reshef, L., Yanai, H. A., Gophna, U., Tulchinsky, H., & Dotan, I. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy370 · Cited by 14
Silva, L. N., Ramos, L. S., Oliveira, S. S. C., Magalhães, L. B., Cypriano, J. B. S., Abreu, F. D. Á., Macêdo, A. J., Branquinha, M. H., & dos Santos, A. L. S. (2023) · Journal of Fungi · doi:10.3390/jof9080859 · Cited by 16
Chavez‐Dozal, A. A., Bernardo, S. M., Rane, H. S., Herrera, G., Kulkarny, V. V., Wagener, J., Cunningham, I., Brand, A., Gow, N. A. R., & Lee, S. A. (2015) · Eukaryotic Cell · doi:10.1128/ec.00028-15 · Cited by 13
“Cell walls from strains THE1CIp10 and tSEC6 (grown in the presence of absence of DOX) were extracted as previously described (29).”
Self-citationRetractedMorales-Menchén, A., Navarro, F., Guirao-Abad, J. P., Román, E., Prieto, D., Coman, I., Plá, J., & Alonso‐Monge, R. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00135 · Cited by 16
“Since no difference could be found in caspofungin susceptibility between Hog1 mutants and wild type strains, the compensatory mechanism of cell wall construction that increase chitin accumulation should not be responsible for the different sensitivity to Dh killer toxin (Lee et al., 2012).”
BackgroundDavis, F. A., Singh, K., Krampen, J. M., Rapala, J. R., Bryant, J. A., McFadden, M. J., Ost, K. S., Esher, S. K., Balunas, M. J., Wang, T., et al. (2026) · Current Biology · doi:10.1016/j.cub.2025.12.029 · Cited by 17
Cordeiro, R. D. A., Evangelista, A. J. D. J., Serpa, R., de Andrade, A. R. C., Mendes, P. B. L., de Oliveira, J. S., de Alencar, L. P., Pereira, V. S., de Lima-Neto, R. G., Brilhante, R. S. N., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01337 · Cited by 13
The Fungal Resistome: A Risk and an Opportunity for the Development of Novel Antifungal Therapies
Reales‐Calderón, J. A., Molero, G., Gil, C., & Martínez, J. L. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0051 · Cited by 15
Ibe, C., Walker, L. A., Gow, N. A. R., & Munro, C. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_16 · Cited by 12
Self-citationShepardson, K. M., & Cramer, R. A. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.03.003 · Cited by 13
Cellular conditions that modulate the fungicidal activity of occidiofungin
Robinson, C. A., Denison, C., Burkenstock, A., Nutter, C., & Gordon, D. M. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13496 · Cited by 13
“…that chitin synthase activities are upregulated under stress and these elevated levels of chitin can provide protection for C. albicans from echinocandin exposure (Munro et al. 2007; Walker et al. 2008; Lee et al. 2012), it is possible that a similar mechanism may be at work for occidiofungin.”
BackgroundWhat ‘Omics can tell us about antifungal adaptation
Ribeiro, G. F., Denes, E., Heaney, H., & Childers, D. S. (2021) · FEMS Yeast Research · doi:10.1093/femsyr/foab070 · Cited by 11
“Cells starved for cell wall β-glucan due to inhibited synthesis compensate by dramatically increasing chitin content in the inner cell wall (Lee et al. 2012; Walker, Gow and Munro 2013).”
BackgroundMendoza, S. R., Liedke, S. C., Noval, C., Ferreira, M. D. S., Gomes, K. X., Honorato, L., Nimrichter, L., Peralta, J. M., & Guimaraes, A. J. (2022) · Medical Mycology · doi:10.1093/mmy/myac050 · Cited by 10
Candida albicans, plasticité et pathogénie
Poulain, D. (2013) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(13)71945-2 · Cited by 16
A novel calcineurin-independent activity of cyclosporin A in Saccharomyces cerevisiae
Singh-Babak, S. D., Shekhar, T., Smith, A. M., Giaever, G. N., Nislow, C., & Cowen, L. E. (2012) · Molecular BioSystems · doi:10.1039/c2mb25107h · Cited by 9
Echinocandin resistance in human pathogenic fungi
Munro, C. A. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.171 · Cited by 9
Self-citationFatima, I., Wakade, G., & Daniell, H. (2025) · Plant Biotechnology Journal · doi:10.1111/pbi.70046 · Cited by 9
Owens, R. A., & Doyle, S. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1912601 · Cited by 11
“caspofungin [95], so chitinase regulation could contribute to the resistance mechanism.”
BackgroundCandida albicans Mannosidases, Dfg5 and Dcw1, Are Required for Cell Wall Integrity and Pathogenesis
Razmi, M., Kim, J.-W., Chinnici, J. L., Busarajan, S., Vuppalapaty, H., Lankipalli, D., Li, R., & Maddi, A. (2024) · Journal of Fungi · doi:10.3390/jof10080525 · Cited by 11
“14 of 16”
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch130 · Cited by 9
New monomeric and dimeric uridinyl derivatives as inhibitors of chitin synthase
Kral, K., Bieg, T., Nawrot, U., Włodarczyk, K., Lalik, A., Hahn, P., & Wandzik, I. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.05.007 · Cited by 7
Biosynthesis and Mechanism of Action of Antifungal Peptidyl Nucleoside Natural Products
Draelos, M. M., & Yokoyama, K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14680-3 · Cited by 8
Zeng, G., Xu, X., Gao, J., Dantas, A. D. S., Gow, N. A. R., & Wang, Y. (2021) · The Cell Surface · doi:10.1016/j.tcsw.2021.100057 · Cited by 9
“albicans resistance against echinocandins, including caspofungin, because higher chitin contents may offset the loss of cell wall integrity caused by echinocandin treatment (Lee et al., 2012; Walker et al., 2008).”
BackgroundSelf-citationQueiroz, M. G., Elsztein, C., & de Morais, M. A. (2019) · Antonie van Leeuwenhoek · doi:10.1007/s10482-019-01335-y · Cited by 7
Commensal to Pathogen Transition of Candida albicans
Niemiec, M. J., Kapitan, M., Polke, M., & Jacobsen, I. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.12077-1 · Cited by 9
Microevolution of Candida glabrata (Nakaseomyces glabrata) during an infection
López-Marmolejo, A. L., Hernández-Chávez, M. J., Gutiérrez‐Escobedo, G., Herrera-Basurto, M. S., Mora-Montes, H. M., Peñas, A. D. L., & Castaño, I. (2024) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2024.103891 · Cited by 7
Ross, Z. K., Alsayegh, S., Zhao, Y., McPherson, S., Munro, C. A., & Lorenz, A. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128322 · Cited by 8
Self-citationArastehfar, A. A., Daneshnia, F., Hovhannisyan, H., Cabrera, N., İlkit, M., Desai, J. V., Gabaldón, T., Shor, E., & Perlin, D. S. (2024) · FEMS Yeast Research · doi:10.1093/femsyr/foae035 · Cited by 7
“On the other hand, 402 echinocandin resistance is accompanied by cell wall changes (32) that may render cell walls more rigid 403 and less permeable for oxidative stress-inducing agents, which may explain how acquisition of ECR 404 mutations rescues the oxidative stress sensitivity and low intra-macrophage fitness of…”
Baicalin promotes β-1,3-glucan exposure in Candida albicans and enhances macrophage response
Pan, Y., Shi, Z., Wang, Y., Chen, F., Yang, Y., Ma, K., & Li, W. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1487173 · Cited by 9
Ibe, C., Otu, A. A., & Pohl, C. H. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2448844 · Cited by 7
“…echinocandin resistant C. auris [58] and C. parapsilosis [34] strains did not harbor the Fks1 and Fks2 hot spot amino acid substitutions, indicating that an entirely different mechanism(s) including cellular modifications [35,88] and genome alterations [37] not show any missense mutations [34].”
A novel renal epithelial cell in vitro assay to assessCandida albicansvirulence
Szabo, E. K., & MacCallum, D. M. (2013) · Virulence · doi:10.4161/viru.27046 · Cited by 7
“Systemic infection is primarily studied in model hosts, such as invertebrate minihosts,(34-39) the chick chorioallantoic membrane model,(40,41) and small mammals.(42-46) However, the mouse intravenous (IV) challenge model remains the most commonly used model to investigate C.”
BackgroundSelf-citationRastogi, S. K., van Wijlick, L., Ror, S., Lee, K. K., Román, E., Agarwal, P., Manzoor, N., Gow, N. A. R., Plá, J., Ernst, J. F., et al. (2019) · Cellular Microbiology · doi:10.1111/cmi.13140 · Cited by 9
“Previous studies have correlated increased susceptibility to cell wall‐damaging agents with alterations in cell wall composition and architecture (Lee et al., 2012).”
BackgroundMethodSelf-citationVázquez-Muñoz, R., Thompson, A. K., Sobue, T., & Dongari‐Bagtzoglou, A. I. (2024) · mBio · doi:10.1128/mbio.02416-24 · Cited by 10
“However, reduction in the cell wall chitin content by this and other chitinases is an important finding since it may increase fungal cell susceptibility to current antifungal therapies such as echinocandins (65).”
BackgroundUpdate on Antifungal Resistance and its Clinical Impact
Posteraro, B., Posteraro, P., & Sanguinetti, M. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0143-0 · Cited by 5
“This Fks1–Fks2 redundancy was shown to attenuate the rate of resistance, as well as the impact of resistanceconferring mutations, whereas their differential regulation can be exploited to reverse the Fks2-mediated resistance [80].”
BackgroundInfluentialThe Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport
Zavřel, M., Esquivel, B. D., & White, T. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0667-3_29-1 · Cited by 7
Commensal to Pathogen Transition of Candida albicans
Jacobsen, I. D., Niemiec, M. J., Kapitan, M., & Polke, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.21281-8 · Cited by 6
Yang, G., Niu, X., Zhuang, T., Zhu, X., Xu, Q., Wang, H., Shao, J., Wang, C., Yang, Y., Wang, T., et al. (2025) · Virulence · doi:10.1080/21505594.2025.2519149 · Cited by 4
Xu, D., Wang, M., Zhang, X., Mao, H., Xu, H., Zhang, B., Zeng, X. W., & Li, F. (2024) · Journal of Fungi · doi:10.3390/jof10050316 · Cited by 4
da Fonseca, D. M., Rodrigues, L., Sousa-Baptista, J., Tejedor, F. M., Mota, M., Cunha, R. A., Fernandes, C., & Gonçalves, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158303 · Cited by 4
Marcos, C. M., de Oliveira, H. C., Assato, P. A., Castelli, R. F., Fusco‐Almeida, A. M., & Mendes‐Giannini, M. J. S. (2021) · Journal of Fungi · doi:10.3390/jof7100852 · Cited by 5
The development of single-domain VHH nanobodies that target the Candida albicans cell surface
Cesare, G. B. D., Sauer, F. M., Kolecka, A., Stavrou, A. A., Verrips, T. C., Boekhout, T., Dolk, E., & Munro, C. A. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.04269-23 · Cited by 4
Self-citationPrusty, J. S., Kumar, A., & Kumar, A. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2418125 · Cited by 8
“A systematic in vivo infection model of candidiasis revealed that the chitin levels in the cell walls of these strains also confer resistance to echino-candins (lee et al. 2012). invertebrates lack chitin, which is identified in the cell wall of the fungus and is required for cell integrity.”
Szigeti, Z. M., Tálas, L., Széles, A., Hargitai, Z., Nagy, Z. L., Nagy, M., Kiss, A., Kéki, S., & Szemán-Nagy, G. (2022) · Journal of Fungi · doi:10.3390/jof8100985 · Cited by 5
“Caspofungin, micafungin and anidulafungin are echinocandins, and inhibit the catalytic subunit of 1,3-β-D-glucan synthase [28], which plays an important role in cell division and cell growth [13].”
BackgroundProteome analysis of Candida albicans cells undergoing chlamydosporulation
Ingle, S., Kazi, R. S., Patil, R., & Zore, G. B. (2019) · Journal of Proteins and Proteomics · doi:10.1007/s42485-019-00024-8 · Cited by 5
Neutralization of Pathogenic Fungi with Small‐Molecule Immunotherapeutics
Chirkin, E., Muthusamy, V., Mann, P. A., Roemer, T., Nantermet, P. G., & Spiegel, D. A. (2017) · Angewandte Chemie · doi:10.1002/ange.201707536 · Cited by 3
Zheng, L., Xu, Y., Wang, C., Yang, F. J., Dong, Y., & Guo, L. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01790-23 · Cited by 3
“Both in vitro and in vivo , elevated chitin confers CSP resistance in C. albicans (23, 24).”
BackgroundDietary tannic acid promotes intestinal clearance of C. albicans by cross-linking hyphal chitosan
Feng, J., Gao, L., Qiu, L., Chao, W., Liu, Y., Wang, R., Yan, L., Jiang, Y., & Lv, Q. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013596 · Cited by 4
“These phenotypes align with previous studies that increased chitin content can enhance C. albicans resistance to both azoles and echinocandins [25–27].”
Caspofungin enhances antifungal immunity in human blood through transcriptional reprogramming
Shehata, A., Schäuble, S., Martin, R., Aldejohann, A. M., Panagiotou, G., Kurzai, O., & Hünniger, K. (2026) · microLife · doi:10.1093/femsml/uqag004 · Cited by 2
“One possible explanation is that the unmasking of immunostimulatory epitopes may be attenuated or counterbalanced by compensatory cell wall re-modeling, such as increased chitin deposition, a mechanism previously linked to echinocandin resistance in vivo (Lee et al. 2012 ).”
Yamada, R., Nakayama, H., Yoshikawa, S., Karita, S., & Umekawa, M. (2026) · FEMS Microbes · doi:10.1093/femsmc/xtag007 · Cited by 2
“While elevated chitin reduces echinocandin susceptibility in C. albicans (Lee et al. 2012 ), our data indicate that increasing UDP-GlcNAc–driven chitin in C. glabrata does not markedly alter caspofungin responses, consistent with the species-specific remodeling reported for C. glabrata under…”
Yang, X., Ge, A., Zhou, H., Hu, C., Yang, X., Song, Z., & Xin, C. (2026) · Future Microbiology · doi:10.1080/17460913.2026.2656109 · Cited by 3
Obeng-Gyasi, O., & Deplazes, E. (2026) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583526100158 · Cited by 3
“For example, studies have shown that high concentrations of echinocandin drugs, used to treat infections caused by Candida spp. or Aspergillus fumigatus , can trigger ‘ paradoxical growth ’ due to increased chitin content (Lee et al. , 2012; Walker et al. , 2013).”
Prażyńska, M. B., & Gospodarek-Komkowska, E. (2018) · The Journal of Antibiotics · doi:10.1038/s41429-018-0123-2 · Cited by 2
Calegari-Alves, Y. P., da Rosa, R. L., Costa, R. P., Innocente-Alves, C., Faustino, A. M., Yates, J. R., Beys‐da‐Silva, W. O., & Santi, L. (2024) · Canadian Journal of Microbiology · doi:10.1139/cjm-2024-0084 · Cited by 5
Malavia, D., Leaves, I., Onime, J., O'Neill, P., Yan, K., Brown, A. J., & Gow, N. A. R. (2026) · The Cell Surface · doi:10.1016/j.tcsw.2026.100170 · Cited by 1
“For example, a reduction in chitin content (as seen in GFA1 repressed mutant) has been associated with increased susceptibility to echinocandins (Lee et al., 2012; Chung et al., 2025).”
Self-citationStrategien bei Versagen einer antimykotischen Therapie auf Intensivstation
Arens, C., Bernhard, M., Koch, C., Heininger, A., Störzinger, D., Hoppe‐Tichy, T., Hecker, M., Grabein, B., Weigand, M. A., & Lichtenstern, C. (2015) · Der Anaesthesist · doi:10.1007/s00101-015-0072-0 · Cited by 1
Ex-chitin-g news on drug-induced fungal epitope unmasking
Wheeler, R. T. (2023) · mBio · doi:10.1128/mbio.01387-23 · Cited by 1
“These responses can drive increased inflammation through increased epitope exposure, can create a cell wall that is more resistant to subsequent antifungal treatment, and can limit pathogenesis in systemic and gastrointestinal models of disease (4–7).”
BackgroundEvolutionary diversity of the control of the azole response by Tra1 across yeast species
Marsiglio-Librais, G. N., Jiang, Y., Razzaq, I., Brandl, C. J., Shapiro, R. S., & Lajoie, P. (2023) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkad250 · Cited by 1
“Echinocandins, such as caspofungin, target the fungal cell wall by inhibiting the synthesis of the carbohydrate β -1,3-glucan (Balashov et al. 2006; Lee et al. 2012), while azoles, such as fluconazole and miconazole, inhibit the synthesis of er-gosterol, thereby compromising the lipid composition…”
BackgroundDisparate Activation of the Inflammasome by Chitin and Chitosan: A Dissertation
Bueter, C. L. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2w02z · Cited by 1
“…integrity, chitin has also been proposed to have a role in epithelial adhesion (Gottlieb et al., 1991; Segal et al., 1988), linkage between cell wall and capsule 3 4 5 (Rodrigues et al., 2008), and antifungal resistance (Lee et al., 2012), making it a polysaccharide of vital importance to fungi.”
BackgroundExploring the role of PTN1 in ustilago maydis.
Pillai, L. V. (2019) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3210 · Cited by 1
Antifungal Activity of Cationic Conjugated Polyelectrolytes and Oligomers against Candida albicans
Ingersol, L. J. (2014) · UNM’s Digital Repository (University of New Mexico)
Kang, Y., & Choi, H. T. (2016) · The Korean Journal of Microbiology · doi:10.7845/kjm.2016.6026
“이 처럼 세포벽 외부의 구조가 변형되고 세포벽의 두께가 감소된 것은 세포벽과 capsule 층이 병원성과 밀접한 관계가 있는 것 (Lee et al., 2012)에 근거하여 chitinase에 의하여 이들의 생장 은 물론 병원성도 감소할 것이라고 판단된다.”
Shekhar‐Guturja, T. (2016) · TSpace (University of Toronto)
Lee, K. K., & Munro, C. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-55013-3_7 · Cited by 1
Self-citationCerebral ischaemia and surgical practice.
Todd, N. V. (1988) · PubMed Central
Perlin, D. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_29
Trentin, G. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-20062022-161952
Antifungal exposure can enhance Candida glabrata pathogenesisPreprint
Ribeiro, G. F., Danecka, W., Tomlinson, L., Wallace, E. W. J., & Childers, D. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.31.667834 · Cited by 1
“Previous studies demonstrated that antifungal treatment leads to differential cell wall gene expression and significant changes in the cell wall that can have paradoxical effects on survival in C. albicans mammalian infections (Hopke et al., 2018; Lee et al., 2012; Walker et al., 2008).”
Alam, K. (2014) · University Library - University of Saskatchewan (University of Saskatchewan)
Metadata
- Authors
- Lee, K. K., MacCallum, D. M., Jacobsen, M. D., Walker, L. A., Odds, F. C., Gow, N. A. R., & Munro, C. A.
- Affiliations
- University of Aberdeen (GB)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2012-01
- Volume
- 56
- Issue
- 1
- Pages
- 208-217
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3256049
- OpenAlex
- W2127997803
- Cited by
- 209
- References
- 77
- Citations by year
- 2026: 11 · 2025: 7 · 2024: 13 · 2023: 11 · 2022: 9 · 2021: 18 · 2020: 20 · 2019: 16 · 2018: 14 · 2017: 15 · 2016: 12 · 2015: 15 · 2014: 19 · 2013: 16 · 2012: 12
- FWCI
- 10.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (086827, 080088)
- University of Aberdeen
- Chinese Academy of Agricultural Sciences
- Biotechnology and Biological Sciences Research Council (BB/F00513X/1)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida albicans, echinocandin resistance, caspofungin, FKS1 mutations, antifungal susceptibility, kidney fungal burden, fungal virulence
- MeSH terms
- Caspofungin, Animals, Antifungal Agents, Candida albicans, Candidiasis, Cell Wall, Chitin, DNA Mutational Analysis, Female, Fungal Proteins, Glucosyltransferases, Kidney, Mice, Inbred BALB C, Microbial Sensitivity Tests, Microscopy, Fluorescence, Mutation, Survival Rate, Amino Acid Substitution, Drug Resistance, Fungal, Mice, Echinocandins, Lipopeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.